Modern radiation therapy for primary cutaneous lymphomas: Field and dose guidelines from the international lymphoma radiation oncology group

International Journal of Radiation Oncology Biology Physics

Volumn 92, Issue 1, 2015, Pages 32-39

  Specht, Lena ^a   Dabaja, Bouthaina ^b   Illidge, Tim ^c   Wilson, Lynn D ^d   Hoppe, Richard T ^e  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; RADIATION; RADIOTHERAPY;

CUTANEOUS LYMPHOMA; MULTI-MODALITY; RADIATION ONCOLOGY; STEERING COMMITTEE;

ONCOLOGY;

B CELL LYMPHOMA; BODY SURFACE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER THERAPY; CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA; CUTANEOUS B CELL LYMPHOMA; CUTANEOUS FOLLICLE CENTER LYMPHOMA; CUTANEOUS MARGINAL ZONE LYMPHOMA; CUTANEOUS T CELL LYMPHOMA; ELECTRON BEAM; GAMMA DELTA T CELL LYMPHOMA; HUMAN; LARGE CELL LYMPHOMA; LEG DISEASE; MARGINAL ZONE LYMPHOMA; MULTICENTER STUDY (TOPIC); MYCOSIS FUNGOIDES; NK T CELL LYMPHOMA; NOSE TUMOR; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION FIELD; REVIEW; SKIN DEFECT; SKIN LYMPHOMA; SKIN SURFACE; SUBCUTANEOUS T CELL LYMPHOMA; SYSTEMIC THERAPY; TREATMENT INDICATION; TUMOR VOLUME; CONSENSUS; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL, CUTANEOUS; PATHOLOGY; PATIENT POSITIONING; PROGNOSIS; SKIN NEOPLASMS;

CONSENSUS; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL, CUTANEOUS; MYCOSIS FUNGOIDES; PATIENT POSITIONING; PROGNOSIS; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; SKIN NEOPLASMS;

EID: 84927562676     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.01.008     Document Type: Review

References (41)

1. S.H. Swerdlow, E. Campo, and N.L. Harris WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 International Agency for Research on Cancer Lyon
2. R. Willemze, E.S. Jaffe, and G. Burg WHO-EORTC classification for cutaneous lymphomas Blood 105 2005 3768 3785
3. Y.H. Kim, R. Willemze, and N. Pimpinelli TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC) Blood 110 2007 479 484
4. H.T. Eich, D. Eich, and O. Micke Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma Int J Radiat Oncol Biol Phys 55 2003 899 906
5. Y.M. Kirova, Y. Piedbois, and J.P. Le Bourgeois Radiotherapy in the management of cutaneous B-cell lymphoma. Our experience in 25 cases Radiother Oncol 52 1999 15 18
6. K.J. Neelis, E.C. Schimmel, and M.H. Vermeer Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas Int J Radiat Oncol Biol Phys 74 2009 154 158
7. N.J. Senff, J.J. Hoefnagel, and K.J. Neelis Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification Arch Dermatol 143 2007 1520 1526
8. B.D. Smith, E.J. Glusac, and J.M. McNiff Primary cutaneous B-cell lymphoma treated with radiotherapy: A comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems J Clin Oncol 22 2004 634 639
9. N.J. Senff, E.M. Noordijk, and Y.H. Kim European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas Blood 112 2008 1600 1609
10. J.J. Hoefnagel, M.H. Vermeer, and P.M. Jansen Primary cutaneous marginal zone B-cell lymphoma: Clinical and therapeutic features in 50 cases Arch Dermatol 141 2005 1139 1145
11. NCCN Clinical Practice Guidelines in Oncology, Non-Hodgkin's Lymphomas Version 1.2015. http://www.nccn.org/professionals/physician-gls/pdf/nhl.pdf. Last accessed Feb. 17, 2015).
12. L. Lowry, P. Smith, and W. Qian Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial Radiother Oncol 100 2011 86 92
13. W. Kempf, K. Pfaltz, and M.H. Vermeer EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: Lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma Blood 118 2011 4024 4035
14. J.B. Yu, J.M. McNiff, and M.W. Lund Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy Int J Radiat Oncol Biol Phys 70 2008 1542 1545
15. F. Grange, M.W. Bekkenk, and J. Wechsler Prognostic factors in primary cutaneous large B-cell lymphomas: A European multicenter study J Clin Oncol 19 2001 3602 3610
16. M. Wobser, H. Kneitz, and E.B. Brocker Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - diagnostic and therapeutic challenges J Dtsch Dermatol Ges 9 2011 204 211
17. L.M. Heinzerling, M. Urbanek, and J.O. Funk Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma Cancer 89 2000 1835 1844
18. E. Olsen, E. Vonderheid, and N. Pimpinelli Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC) Blood 110 2007 1713 1722
19. N.S. Agar, E. Wedgeworth, and S. Crichton Survival outcomes and prognostic factors in mycosis fungoides/Sezary syndrome: Validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal J Clin Oncol 28 2010 4730 4739
20. M.F. Benner, P.M. Jansen, and M.H. Vermeer Prognostic factors in transformed mycosis fungoides: A retrospective analysis of 100 cases Blood 119 2012 1643 1649
21. E.C. Benton, S. Crichton, and R. Talpur A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome Eur J Cancer 49 2013 2859 2868
22. S.I. Jawed, P.L. Myskowski, and S. Horwitz Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): Part II. Prognosis, management, and future directions J Am Acad Dermatol 70 2014 223.e1-17
23. J.S. Lehman, R.H. Cook-Norris, and B.R. Weed Folliculotropic mycosis fungoides: Single-center study and systematic review Arch Dermatol 146 2010 607 613
24. T.O. Thomas, P. Agrawal, and J. Guitart Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma Int J Radiat Oncol Biol Phys 85 2013 747 753
25. B. Micaily, C. Miyamoto, and G. Kantor Radiotherapy for unilesional mycosis fungoides Int J Radiat Oncol Biol Phys 42 1998 361 364
26. L.D. Wilson, B.M. Kacinski, and G.W. Jones Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (Mycosis Fungoides) Int J Radiat Oncol Biol Phys 40 1998 109 115
27. R.T. Hoppe, Z. Fuks, and M.A. Bagshaw The rationale for curative radiotherapy in mycosis fungoides Int J Radiat Oncol Biol Phys 2 1977 843 851
28. C. Harrison, J. Young, and D. Navi Revisiting low-dose total skin electron beam therapy in mycosis fungoides Int J Radiat Oncol Biol Phys 81 2011 e651 e657
29. R.T. Hoppe, C. Harrison, and M. Tavallaee Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials J Am Acad Dermatol 72 2015 286 292
30. M.R. Kamstrup, L.M. Lindahl, and R. Gniadecki Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: An open-label prospective phase II study Br J Dermatol 166 2012 399 404
31. G.W. Jones, B.M. Kacinski, and L.D. Wilson Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group J Am Acad Dermatol 47 2002 364 370
32. F. Trautinger, R. Knobler, and R. Willemze EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome Eur J Cancer 42 2006 1014 1030
33. T. Piotrowski, P. Milecki, and M. Skorska Total skin electron irradiation techniques: A review Postepy Dermatol Alergol 30 2013 50 55
34. Z. Chen, A.G. Agostinelli, and L.D. Wilson Matching the dosimetry characteristics of a dual-field Stanford technique to a customized single-field Stanford technique for total skin electron therapy Int J Radiat Oncol Biol Phys 59 2004 872 885
35. R.S. Cox, R.J. Heck, and P. Fessenden Development of total-skin electron therapy at two energies Int J Radiat Oncol Biol Phys 18 1990 659 669
36. R.T. Hoppe Mycosis fungoides: Radiation therapy Dermatol Ther 16 2003 347 354
37. M.D. Evans, C. Hudon, and E.B. Podgorsak Institutional experience with a rotational total skin electron irradiation (RTSEI) technique - a three decade review (1981-2012) Rep Pract Oncol Radiother 19 2014 120 134
38. F.W. Hensley, G. Major, and C. Edel Technical and dosimetric aspects of the total skin electron beam technique implemented at Heidelberg University Hospital Rep Pract Oncol Radiother 19 2014 135 143
39. T.H. Kim, C. Pla, and M. Pla Clinical aspects of a rotational total skin electron irradiation Br J Radiol 57 1984 501 506
40. W. Sewchand, F.M. Khan, and J. Williamson Total-body superficial electron-beam therapy using a multiple-field pendulum-arc technique Radiology 130 1979 493 498
41. J.M. Wu, S.W. Leung, and C.J. Wang Lying-on position of total skin electron therapy Int J Radiat Oncol Biol Phys 39 1997 521 528